145 related articles for article (PubMed ID: 10357988)
1. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure.
Tal J; Schliamser LM; Leibovitz Z; Ohel G; Attias D
Hum Reprod; 1999 Jun; 14(6):1624-7. PubMed ID: 10357988
[TBL] [Abstract][Full Text] [Related]
2. Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss.
Younis JS; Brenner B; Ohel G; Tal J; Lanir N; Ben-Ami M
Am J Reprod Immunol; 2000 Jan; 43(1):31-5. PubMed ID: 10698038
[TBL] [Abstract][Full Text] [Related]
3. Screening for activated protein C resistance before oral contraceptive treatment: a pilot study.
Palareti G; Legnani C; Frascaro M; Flamigni C; Gammi L; Gola G; Fuschini G; Coccheri S
Contraception; 1999 May; 59(5):293-9. PubMed ID: 10494482
[TBL] [Abstract][Full Text] [Related]
4. Coagulation inhibitors and activated protein C resistance in recurrent pregnancy losses in Indian women.
Jyotsna PL; Sharma S; Trivedi SS
Indian J Pathol Microbiol; 2011; 54(4):752-5. PubMed ID: 22234103
[TBL] [Abstract][Full Text] [Related]
5. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage.
Sarig G; Younis JS; Hoffman R; Lanir N; Blumenfeld Z; Brenner B
Fertil Steril; 2002 Feb; 77(2):342-7. PubMed ID: 11821094
[TBL] [Abstract][Full Text] [Related]
6. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus.
Male C; Mitchell L; Julian J; Vegh P; Joshua P; Adams M; David M; Andrew ME
Blood; 2001 Feb; 97(4):844-9. PubMed ID: 11159506
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of smoking as a risk factor for activated protein C resistance during pregnancy.
Kafkas S; Kalkan U; Bolaman Z; Sanci M; Yüksel H; Odabaşi AR
Gynecol Obstet Invest; 2007; 64(2):89-94. PubMed ID: 17314487
[TBL] [Abstract][Full Text] [Related]
8. [Activated protein C resistance as a cause of thrombophilia].
Ruiz-Argüelles GJ
Rev Invest Clin; 1996; 48(3):223-9. PubMed ID: 8966383
[TBL] [Abstract][Full Text] [Related]
9. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON
Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies.
Mello G; Parretti E; Martini E; Mecacci F; La Torre P; Cioni R; Lucchetti R; Fedi S; Gori AM; Pepe G; Prisco D; Abbate R
Haemostasis; 1999; 29(4):197-203. PubMed ID: 10702700
[TBL] [Abstract][Full Text] [Related]
11. Placental histomorphology in unexplained foetal loss with thrombophilia.
Vora S; Shetty S; Khare M; Ghosh K
Indian J Med Res; 2009 Feb; 129(2):144-9. PubMed ID: 19293440
[TBL] [Abstract][Full Text] [Related]
12. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
13. [Frequency of antiphospholipid antibodies and factor V (G1691A), prothrombin (G20210A) gene polimorphism among women with pregnancy complications].
Rajewski M; Skrzypczak J
Pol Arch Med Wewn; 2006 May; 115(5):417-25. PubMed ID: 17195354
[TBL] [Abstract][Full Text] [Related]
14. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
Simkova M; Simko F; Kovacs L
Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Espinosa G; Cervera R; Carmona F; Balsch J; Ingelmo M; Ordinas A
Lupus; 2002; 11(11):730-5. PubMed ID: 12475003
[TBL] [Abstract][Full Text] [Related]
16. Thrombophilia investigation in Pakistani women with recurrent pregnancy loss.
Hossain N; Shamsi T; Khan N; Naz A
J Obstet Gynaecol Res; 2013 Jan; 39(1):121-5. PubMed ID: 22690883
[TBL] [Abstract][Full Text] [Related]
17. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
[TBL] [Abstract][Full Text] [Related]
18. Thrombophilic dimension of recurrent fetal loss in Indian patients.
Vora S; Shetty S; Ghosh K
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):581-4. PubMed ID: 18685442
[TBL] [Abstract][Full Text] [Related]
19. Congenital resistance to activated protein C in patients with lupus anticoagulants: evaluation of two functional assays.
Galli M; Duca F; Ruggeri L; Finazzi G; Negri B; Moia M
Thromb Haemost; 1998 Aug; 80(2):246-9. PubMed ID: 9716147
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries.
Dacosta A; Tardy-Poncet B; Isaaz K; Cerisier A; Mismetti P; Simitsidis S; Reynaud J; Tardy B; Piot M; Decousus H; Guyotat D
Heart; 1998 Oct; 80(4):338-40. PubMed ID: 9875108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
